Convicted businessman and former sports leader Umarji Aiyaz Mohammed Musa has returned to Fiji, but he is still facing significant legal challenges. After serving a reduced prison sentence in New Zealand for drug importation, Musa is now under investigation by Fijian authorities for serious crimes.
Musa was sentenced to four years in prison in August 2023 for smuggling $5 million worth of pseudoephedrine from Fiji to New Zealand, a substance used in the manufacture of methamphetamine. His connections to the crime were established through his ownership of over ten pharmacies throughout the Pacific region. Following an appeal, he received a six-month reduction in his sentence and returned to Fiji last Wednesday.
Assistant Commissioner of Police (ACP) Mesake Waqa confirmed that investigations are still active, targeting organized crime, drug trafficking, money laundering, and misappropriation of funds. The Criminal Investigations Department (CID) and the Serious Organised Crime Unit are leading the investigation, which stems from reports provided by the Fiji Financial Intelligence Unit.
“There are still active investigations into these matters, and we are pursuing them with due diligence,” stated ACP Waqa.
Minister for Home Affairs and Immigration Pio Tikoduadua emphasized the government’s commitment to fighting crime, insisting that “no one is above the law.” He recognized Musa’s return but refrained from sharing further details, citing the sensitive nature of the ongoing inquiry.
“We remain resolute in our fight against narcotics and organized crime,” Mr. Tikoduadua said, adding that law enforcement will ensure due process is followed in every investigation to safeguard communities from the dangers of illicit activities.
Musa, previously the vice-president of the Fiji Football Association and a prominent businessman with interests in pharmacies, restaurants, and real estate, saw his reputation dramatically tarnished following his arrest and subsequent conviction, which reverberated throughout Fiji, affecting both the sporting and pharmaceutical sectors.